Medindia

X

Potential Threat of the Zika Virus to World Blood Supply Deserves Study and Action

by Dr. Trupti Shirole on  June 15, 2016 at 6:10 AM Tropical Disease News   - G J E 4
Zika virus, once mainly seen in parts of Asia and Africa, has spread through the Americas and is now transmitted by mosquitoes in Puerto Rico. Mosquito-related transmission has not been reported yet in the continental United States, but people who have traveled to areas where active transmission by mosquitoes occurred have developed the infection upon their return to the U.S. The virus has been linked to birth defects and neurological disease, with thousands of cases being reported in Brazil.
 Potential Threat of the Zika Virus to World Blood Supply Deserves Study and Action
Potential Threat of the Zika Virus to World Blood Supply Deserves Study and Action
Advertisement

Blood safety researchers say it is highly likely that the mosquito-borne Zika virus can be transmitted through blood transfusions and are calling for an evidence-based approach to protecting the blood supply from the threat of Zika virus, suggested a commentary in the journal Transfusion.

‘The Zika virus can be transmitted through blood transfusions. Therefore, researchers are calling for an evidence-based approach to protect the blood supply from the threat of Zika virus.’
Advertisement
The researchers say among several possible steps that could be taken to mitigate safety concerns: deferring blood donors who have symptoms of the infection, developing better blood screening tests, and finding ways to reduce the pathogen.

Based on the growing concern over Zika and the blood supply, the National Institutes of Health in February announced interest in supporting research that examines the risk of Zika transmission through transfusion and the potential clinical impact of Zika that might be passed along through blood. In addition the NIH's National Heart, Lung, and Blood Institute (NHLBI) has made Zika research part of the existing Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) blood safety research program.

Source: Eurekalert
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All